Compare SURG & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SURG | COCH |
|---|---|---|
| Founded | 2006 | 1995 |
| Country | United States | United States |
| Employees | 20 | 47 |
| Industry | Advertising | Blank Checks |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.8M | 50.6M |
| IPO Year | N/A | N/A |
| Metric | SURG | COCH |
|---|---|---|
| Price | $0.51 | $0.65 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $5.00 | ★ $6.00 |
| AVG Volume (30 Days) | ★ 578.5K | 116.1K |
| Earning Date | 04-14-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $136.77 | $1.58 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.46 | $0.36 |
| 52 Week High | $3.45 | $1.89 |
| Indicator | SURG | COCH |
|---|---|---|
| Relative Strength Index (RSI) | 39.00 | 44.38 |
| Support Level | $0.48 | $0.63 |
| Resistance Level | $0.94 | $0.73 |
| Average True Range (ATR) | 0.07 | 0.04 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 19.94 | 23.55 |
Surgepays Inc is a wireless and point of sale technology company focused on serving underserved and value-conscious consumers through a combination of retail distribution and digital acquisition channels. It provides mobile connectivity, financial technology services, and transaction processing solutions through an integrated platform that combines wireless services with point of sale software and retail distribution. It enables in-store and online activation of wireless services, prepaid top-ups, and financial transactions, allowing consumers to access essential services in both local and digital environments. Its segments are wireless services or MVNO Telecommunications, platform services or MVNE Enablement Platform (HERO), and wholesale enablement or Comprehensive Platform Services.
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.